Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by 4Justiceon Jul 20, 2021 10:47pm
58 Views
Post# 33579783

RE:RE:WAKE UP

RE:RE:WAKE UP

He genious! 

You believe that an income of $70 millions comming from the sale of a division that had a value of over $500 millions will raise the market cap to $1 billion ?

They burn $5 millions a month and have nothing close to commercialisation.

The Market is not dreaming like you. They evaluate the management, the business plan, what they delivered and the conclusion is... BELOW $4

Consonnance Capital losted over $30 millions in this misleading story.

Hi! Hi! No one wants to buy your shares for cheap! Keep it my friend ... if you realy have one !!!???

<< Previous
Bullboard Posts
Next >>